IRONWOOD PHARMACEUTICALS INC (IRWD)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, IRONWOOD PHARMACEUTICALS INC reported revenue of $296.15M, down 15.7% from the prior year. The company was profitable, with a net margin of 8.1%.
Key ratios (FY2025)
33.3%
Operating margin
8.1%
Net margin
-15.7%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $296.15M | $351.41M | $442.74M | $410.60M | $413.75M | $389.52M | $428.41M | $346.64M | $298.28M | $273.96M |
| Cost of Revenue | — | — | — | — | — | $3.14M | $23.88M | $32.75M | $19.10M | $1.87M |
| Operating Income | $98.50M | $93.12M | -$945.43M | $250.34M | $232.26M | $142.94M | $120.12M | -$150.67M | -$15.36M | -$51.87M |
| Net Income | $24.02M | $880.0K | -$1.03B | $175.06M | $528.45M | $106.18M | $21.50M | -$282.37M | -$116.94M | -$81.71M |
| EPS (Diluted) | $0.15 | $0.01 | $-6.45 | $0.96 | $3.21 | $0.66 | $0.14 | $-1.85 | — | — |
| Total Assets | $396.90M | $350.91M | $471.07M | $1.10B | $1.13B | $559.24M | $402.75M | $332.05M | $605.67M | $709.82M |
| Shareholders' Equity | -$261.83M | -$301.33M | -$346.30M | $652.38M | $605.91M | $62.64M | -$93.25M | -$196.37M | $9.85M | $66.72M |
| Cash & Equivalents | $215.46M | $88.56M | $92.15M | $656.20M | $620.13M | $362.56M | $177.02M | $173.17M | $125.74M | $54.00M |
| Operating Cash Flow | $127.04M | $103.55M | $183.43M | $273.76M | $261.89M | $168.84M | $10.72M | -$70.88M | -$100.75M | -$25.93M |
| Capital Expenditures | $34.0K | $142.0K | $273.0K | $136.0K | $265.0K | $1.84M | $7.19M | $351.0K | $2.80M | $4.21M |
| Shares Outstanding | 162.98M | 160.08M | 155.44M | 186.31M | 164.42M | 160.66M | 156.02M | 152.63M | — | — |